Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with D

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
1616 Q3 2021 D&C RED NO. 27 ALUMINUM LAKE ORAL TABLET 0.69 mg MDE Replacement
1616 Q4 2021 D&C RED NO. 27 ALUMINUM LAKE ORAL TABLET 1.2 mg MDE Replacement
1641 Q3 2021 D&C RED NO. 30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.30 mg MDE Replacement
1641 Q4 2021 D&C RED NO. 30 ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.6 mg MDE Replacement
1653 Q3 2021 D&C RED NO. 30 ALUMINUM LAKE ORAL TABLET, COATED 0.34 mg MDE Replacement
1653 Q4 2021 D&C RED NO. 30 ALUMINUM LAKE ORAL TABLET, COATED 4.96 mg MDE Replacement
1731 Q3 2021 D&C YELLOW NO. 10 ALUMINUM LAKE BUCCAL GUM, CHEWING 2.40 mg MDE Replacement
1731 Q4 2021 D&C YELLOW NO. 10 ALUMINUM LAKE BUCCAL GUM, CHEWING 40.4 mg MDE Replacement
1744 Q3 2021 D&C YELLOW NO. 10 ALUMINUM LAKE ORAL TABLET, EXTENDED RELEASE 2.82 mg MDE Replacement
1744 Q4 2021 D&C YELLOW NO. 10 ALUMINUM LAKE ORAL TABLET, EXTENDED RELEASE 4 mg MDE Replacement
1850 Q3 2021 DIBASIC CALCIUM PHOSPHATE DIHYDRATE ORAL TABLET, FILM COATED 635.50 mg MDE Replacement
1850 Q4 2021 DIBASIC CALCIUM PHOSPHATE DIHYDRATE ORAL TABLET, FILM COATED 953.28 mg MDE Replacement
1861 Q3 2021 DIBUTYL SEBACATE ORAL CAPSULE 15.47 mg MDE Replacement
1861 Q4 2021 DIBUTYL SEBACATE ORAL CAPSULE 30.94 mg MDE Replacement
1867 Q3 2021 DIBUTYL SEBACATE ORAL TABLET 6.00 mg MDE Replacement
1867 Q4 2021 DIBUTYL SEBACATE ORAL TABLET 22.75 mg MDE Replacement
1889 Q3 2021 DIETHYL PHTHALATE ORAL CAPSULE 9.57 mg MDE Replacement
1889 Q4 2021 DIETHYL PHTHALATE ORAL CAPSULE 19.14 mg MDE Replacement
1927 Q3 2021 DIMETHICONE 350 TOPICAL CREAM 1.00 %w/w MDE Replacement
1927 Q4 2021 DIMETHICONE 350 TOPICAL CREAM 114 mg MDE Replacement
2010 Q3 2021 DYE BROWN LAKE BLEND BUCCAL GUM, CHEWING 0.17 mg MDE Replacement
2010 Q4 2021 DYE BROWN LAKE BLEND BUCCAL GUM, CHEWING 3.4 mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English